Key Segments:
By Offering
-
End-to-End Solutions
-
Niche and Point Solutions
-
AI Technology
-
Services
By Application
-
Clinical
-
Non-Clinical
By Component
-
Software
-
Services
By End User
-
CRO & CDMO
-
Pharmaceutical Companies
-
Biotechnology Companies
-
Diagnostic Companies
-
Academic & Government Laboratories
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes NVIDIA, Alphabet, Tempus AI, Dassault Systèmes, Recursion Pharmaceuticals, Schrödinger, Microsoft, Insilico Medicine, Owkin, PathAI, Aidoc, Qure.ai, SOPHiA GENETICS and SandboxAQ, among others.
The main opportunities lie in sovereign and government-backed capital flowing into AI-driven life-science infrastructure, and in the rise of AI-native biotechnology companies structuring milestone-bearing vendor partnerships rather than conventional software licenses.
The key growth factor is the shift from pilot-scale AI experimentation toward infrastructure-scale, multi-year partnerships that commit dedicated compute capacity, reinforced by accumulating regulatory precedent for AI-assisted tools.
By offering, the End-to-End Solutions segment dominated the market with approximately 36.80% share in 2025, as sponsors favor one accountable vendor spanning model, compute and workflow.
North America dominated the market with approximately 47.60% share in 2025, supported by its concentrated pharmaceutical R&D base. Asia Pacific is the fastest-growing region with a projected CAGR of approximately 29.70% from 2026 to 2035.
